(Q54099059)

24 May 2018

title

Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group. (English)

1 reference

24 May 2018

author name string

M J Brodie

series ordinal

1

1 reference

24 May 2018

J P Mumford

series ordinal

2

1 reference

24 May 2018

publication date

1 April 1999

1 reference

24 May 2018

published in

Epilepsy Research

1 reference

24 May 2018

volume

34

1 reference

24 May 2018

issue

2-3

1 reference

24 May 2018

page(s)

199-205

1 reference

24 May 2018

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900110-7

1 reference

7 January 2021

Established antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900110-7

7 January 2021

Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900110-7

7 January 2021

Antiepileptic drugs, clinical trials, and the marketplace

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900110-7

7 January 2021

Experimental studies and controlled clinical testing of valproate and vigabatrin

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900110-7

7 January 2021

New antiepileptic drugs--an explosion of activity

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900110-7

7 January 2021

The new antiepileptic drugs: a systematic review of their efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900110-7

7 January 2021

Update on the mechanism of action of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900110-7

7 January 2021

Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900110-7

7 January 2021

Rational polypharmacy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900110-7

7 January 2021

Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizures. The M88-194 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2898%2900110-7

7 January 2021

10.1016/S0920-1211(98)00110-7

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018